Memo Therapeutics

parachute snow mountains

Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders

Ex-CRISPR Tx CMO lands at Takeda. Lexeo adds Pfizer rare disease leader as development chief. Merck & Co. leader to join Cartography.

Max Bayer , Gabrielle Masson Feb 9, 2024 9:30am

A vial with a check mark indicating COVID-19 positivity

Prepping the next generation of COVID-19 vaccines and treatments

May 17, 2021 9:25am